Medindia

X

Cumberland Pharmaceuticals to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London

Thursday, May 12, 2011 General News J E 4
Advertisement

NASHVILLE, Tenn., May 11, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the 2011 UBS Global Specialty Pharmaceuticals Conference in London on Wednesday, May 25, 2011, at 12:30 p.m.

The presentation will be simultaneously webcast and can be accessed by visiting the Investor Relations section of Cumberland Pharmaceuticals' website at www.cumberlandpharma.com.

Shortly following the live webcast a replay will also be available on the Company's website.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc. is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland's marketed products include AcetadoteŽ for the treatment of acetaminophen poisoning, CaldolorŽ, the first injectable treatment for pain and fever approved in the United States, and KristaloseŽ, a prescription laxative. Cumberland is dedicated to providing innovative products which improve quality of care for patients. For more information, please visit the Company website at www.cumberlandpharma.com.

SOURCE Cumberland Pharmaceuticals Inc.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Bionovo Announces First Quarter 2011 Highlights an...
S
jcpenney Designer Takes Top Honors at DIFFA/Dallas...